Pacific Palisades, CA, United States of America

Daniel E Afar

This inventor holds 36 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 8 EPO patents, primarily in Cancer Antibody Therapy. Top assignees: Agensys, Inc., Facet Biotech Corporation, Genentech, Inc.. Active years: 2001-2013.

USPTO Granted Patents = 36 (Patent Applications = 7)

% Patents Active = 58.3

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 4.5

ph-index = 13

Forward Citations = 481(Granted Patents)

Location History:

Mountain View, CA (US) (2010)
Brisbane, CA (US) (2007 - 2012)
Fremont, CA (US) (2010 - 2012)
Pacific Palisades, CA (US) (2001 - 2013)
Short Hills, NJ (US) (2013)

Company Filing History:

Facet Biotech Corporation

Abbott Biotherapeutics Corp.

patents

5. 1 out of 52

Abbvie Biotherapeutics Inc.

The Cleveland Clinic Foundation

where one patent can have more than one assignee

Years Active: 2001-2013

Loading Chart...

Areas of Expertise:

Anti-CS1 Antibodies

TMEFF2 Antigens

Transmembrane Proteins

Prostate Cancer

Bladder Cancer

Lymphoma Treatment

Nucleic Acid

BPC-1 Protein

STEAP1 Antibodies

Testis-Specific Proteins

Cancer Detection

Peptides

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8603477 - Use of anti-CS1 antibodies for treatment of rare lymphomas (2013-12-10),

2. 8414898 - Serpentine transmembrane antigens expressed in human cancers and uses thereof (2013-04-09),

3. 8383777 - 13-transmembrane protein expressed in prostate cancer (2013-02-26),

4. 8257708 - Antibodies against cancer antigen TMEFF2 and uses thereof (2012-09-04),

5. 8173381 - Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer (2012-05-08),

6. 8053551 - Serpentine transmembrane antigens expressed in human cancers and uses therefor (2011-11-08),

7. 8003758 - BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells (2011-08-23),

8. 7968307 - Serpentine transmembrane antigens expressed in human cancers and uses thereof (2011-06-28),

9. 7928201 - Serpentine transmembrane antigens expressed in human cancers and uses thereof (2011-04-19),

10. 7842293 - Compositions and methods using anti-CS1 antibodies to treat multiple myeloma (2010-11-30),

11. 7824678 - Antibodies against cancer antigen TMEFF2 and uses thereof (2010-11-02),

12. 7803916 - Gene expressed in prostate cancer (2010-09-28),

13. 7785816 - Antibodies against cancer antigen TMEFF2 and uses thereof (2010-08-31),

14. 7785811 - BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells (2010-08-31),

15. 7727533 - Serpentine transmembrane antigens expressed in human cancers and uses thereof (2010-06-01),

Title: The Innovative Journey of Daniel E Afar

Introduction:

Daniel E Afar, a distinguished inventor hailing from Pacific Palisades, CA, has made significant contributions to the field of technology and innovation.

Latest Patents:

Daniel E Afar holds several patents in various technological domains, showcasing his versatility and creativity in inventing cutting-edge solutions.

Career Highlights:

With a career spanning over two decades, Daniel E Afar has been at the forefront of technological advancements, consistently pushing the boundaries of innovation. His work has revolutionized industries and improved the lives of many.

Collaborations:

Throughout his career, Daniel E Afar has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work in diverse teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, Daniel E Afar's passion for innovation and his dedication to creating impactful solutions have solidified his position as a prominent figure in the world of inventors. His relentless pursuit of excellence continues to inspire future generations of innovators.